Omecamtiv mecarbil in precision-cut living heart failure slices: A story of a double-edged sword
Heart failure (HF) is a rapidly growing pandemic while medical treatment options remain limited. Omecamtiv mecarbil (OM) is a novel HF drug that directly targets the myosin heads of the cardiac muscle. This study used living myocardial slices (LMS) from patients with HF to evaluate the direct biomec...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2023-09-01
|
| Col·lecció: | Journal of Molecular and Cellular Cardiology Plus |
| Matèries: | |
| Accés en línia: | http://www.sciencedirect.com/science/article/pii/S2772976123000107 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|